Latest News

  • MARKET TRENDS

    19 Feb 2026

    AAV Arms Race: Who Controls Gene Therapy’s Future?

  • INNOVATION

    11 Feb 2026

    NanoMosaic Win Highlights Manufacturing’s New Frontier

  • MARKET TRENDS

    5 Feb 2026

    The Race to Modernize Viral Vector Production

  • PARTNERSHIPS

    3 Feb 2026

    Gene Therapy Grows Up as US Manufacturing Hits Its Stride

SMA Gets a Bigger Tool Kit as Gene Therapy Steps Up

Itvisma gene therapy packaging and vials used for spinal muscular atrophy treatment

INNOVATION

29 Nov 2025

Itvisma’s expanded FDA label opens treatment to older SMA patients and hints at broader gene therapy momentum

Cleanroom technician in protective suit inside pharmaceutical manufacturing facility

MARKET TRENDS

19 Feb 2026

AAV Arms Race: Who Controls Gene Therapy’s Future?

As AAV demand surges, biotech firms race to lock in manufacturing capacity, reshaping alliances and competition across gene therapy

Automated biotech instrument performing AAV analytics

INNOVATION

11 Feb 2026

NanoMosaic Win Highlights Manufacturing’s New Frontier

FDA nod to NanoMosaic’s Nanoneedle tech signals analytics as the new frontier in AAV manufacturing

Automated biomanufacturing facility with control panels and cleanroom layout

MARKET TRENDS

5 Feb 2026

The Race to Modernize Viral Vector Production

Automation and consolidation are reshaping viral vector manufacturing, forcing producers to modernize early to stay competitive and reliab...

Oxford Biomedica branding over laboratory scene linked to viral vector manufacturing

PARTNERSHIPS

3 Feb 2026

Gene Therapy Grows Up as US Manufacturing Hits Its Stride

A North Carolina facility acquisition highlights a shift toward commercial gene therapy manufacturing as developers seek to reduce supply ...

Itvisma gene therapy packaging and vials used for spinal muscular atrophy treatment

INNOVATION

29 Nov 2025

SMA Gets a Bigger Tool Kit as Gene Therapy Steps Up

Itvisma’s expanded FDA label opens treatment to older SMA patients and hints at broader gene therapy momentum

Digital illustration representing viral vectors delivering genetic material

MARKET TRENDS

25 Nov 2025

Inside the US Rush to Rule Viral Vector Supply

Rising gene therapy demand pushes firms to streamline operations and invest in new platforms

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.